Evidence map›Paper›PMID 24566190›Full record

ArticleAntimicrobial agents and chemotherapy2014

Polyethylene glycol-based hydrogels for controlled release of the antimicrobial subtilosin for prophylaxis of bacterial vaginosis.

Sujata Sundara Rajan, Veronica L Cavera, Xiaoping Zhang, Yashveer Singh, Michael L Chikindas, Patrick J Sinko

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Review
  3. Fabrication and characterization of bioprints with Lactobacillus crispatus for vaginal application.Journal of controlled release : official journal of the Controlled Release Society · 2023
    Article
  4. Article
  5. Review
  6. Article
  7. Functions and emerging applications of bacteriocins.Current opinion in biotechnology · 2018
    Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Sujata Sundara RajanDepartment of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, New Brunswick, New Jersey, USA.
Veronica L Cavera
Xiaoping Zhang
Yashveer Singh
Michael L Chikindas
Patrick J Sinko
Rutgers, The State University of New Jersey · US

Funding

Multiplex Nanocarrier-based Hydrogels for Prevention of Vaginal HIV Transmission.R01AI084137 · NIAID · RUTGERS, THE STATE UNIV OF N.J. · PI SINKO, PATRICK J. · 2009 to 2012
$1.5M
NIAID NIH HHS R01 AI084137NIAID NIH HHS R01AI084137
6 · The paper itself

Abstract

Current treatment options for bacterial vaginosis (BV) have been shown to be inadequate at preventing recurrence and do not provide protection against associated infections, such as that with HIV. This study examines the feasibility of incorporating the antimicrobial peptide subtilosin within covalently cross-linked polyethylene glycol (PEG)-based hydrogels for vaginal administration. The PEG-based hydrogels (4% and 6% [wt/vol]) provided a two-phase release of subtilosin, with an initial rapid release rate of 4.0 μg/h (0 to 12 h) followed by a slow, sustained release rate of 0.26 μg/h (12 to 120 h). The subtilosin-containing hydrogels inhibited the growth of the major BV-associated pathogen Gardnerella vaginalis with a reduction of 8 log10 CFU/ml with hydrogels containing ≥15 μg entrapped subtilosin. In addition, the growth of four common species of vaginal lactobacilli was not significantly inhibited in the presence of the subtilosin-containing hydrogels. The above findings demonstrate the potential application of vaginal subtilosin-containing hydrogels for prophylaxis of BV.

Indexed as

Anti-Infective AgentsBacteriocinsFemaleGardnerella vaginalisHumansHydrogelsLactobacillus acidophilusPeptides, CyclicPolyethylene GlycolsVaginosis, BacterialAnti-Infective AgentsBacteriocinsHydrogelsPeptides, CyclicPolyethylene GlycolssboA protein, Bacillus subtilis

Identifiers

PMID24566190
PMCPMC3993243
OpenAlexW2116141311

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.